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Abstract
USING AN ELECTRONIC REMINDER TO IMPROVE PHYSICIAN PRACTICES AT YALE-NEW
HAVEN HOSPITAL. Alicia I. Arbaje and Victor Morris. Department of Internal Medicine, Yale
University, School ofMedicine, New Haven, CT.
The inappropriate use of diphenhydramine (Benadryl) can lead to iatrogenic complications,
such as cognitive decline. Electronic reminders can be effective in implementing clinical guidelines,
providing decision support to clinicians, and reducing medical errors. The purpose of this study was to
determine the effect of an electronic reminder screen on physicians' routine use of diphenhydramine as a
pretreatment prior to blood transfusions, and to assess their attitudes regarding this reminder.
The researchers reviewed diphenhydramine use in adult inpatients before, immediately after, and
one year after implementation of the reminder screen. A total of 752 transfusion episodes (467 patients)
were reviewed, with 253 in the pre-screen group, 249 in the post-screen group, and 250 in the post-screen
comparison group. The mean age in each group was 66 years (SD=15), 64 years (SD=15), and 69 years
(SD=12), respectively. Diphenhydramine use decreased significantly after screen implementation from
41% to 20% (p<0.005) the first year and down to 12% (p<0.005) the second year. An analysis in the
medical, surgical, and obstetrics/gynecology services demonstrated significant absolute reductions over
time (38.6%, 28.1%, and 4.6% reductions, respectively, p<0.05). Only 17% of all treated patients had a
documented indication for diphenhydramine. Treated patients had higher rates of mental status change
than non-treated patients32/83 (39%) vs. 92/513 (18%, p<0.0005).
Fifty-six house staff completed a questionnaire regarding the electronic reminder (estimated
response rate 53%). Sixty-nine percent reported ordering diphenhydramine less than 25% of the time
(SD=0.9), 71%o were aware of blood bank pretreatment recommendations (SD=0.5), 55% had seen the
reminder (SD=0.5), 59% changed their behavior due to the reminder (SD=0.7), and 65% felt the reminder
was helpful and should remain in the system (SD=0.9).
Diphenhydramine use significantly declined immediately and overtime with the implementation
of an electronic reminder, supporting the use of this mechanism to impact physician practice patterns.
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6Overview
This thesis will:
1 . Discuss the quality of health care delivery in the context of recent
trends in American medicine.
2. Describe a systems-based approach to the improvement of health care
delivery incorporating information technology.
3. Present a quantitative study evaluating the use of electronic reminders
in the hospital setting.
4. Provide an analysis of the study ramifications as they relate to
physician practice patterns.
Introduction
Part I: The Need for Improvement in the Delivery of Medical Care.
1.1 Historical Perspective
The practice ofAmerican medicine is no longer what it used to be. It has
redefined itself amidst turbulent historical movements. The emergence of third-party
payment systems, fueled by the Great Depression and the need for guaranteed payment of
rapidly rising hospital costs, served to increase access (to those eligible) without
implementing major cost controls. Over the past 40 years, escalating costs, combined
with the lack of state regulation, increasing power of the AMA, medicalization of
behavior and its role in disease, duplication of medical services, growth ofmedical
technology and the pharmaceutical industry(l), and the public's demand for it(2), has led
to health care consumers calling for a reevaluation of the U.S. health care system(3).
71.2 Geographic Variation in Health Care
The emergence ofmanaged care has been a response to this reevaluation.
Considerable geographic variation exists in the use of a variety of health care services.
including hysterectomies(4), coronary angiography and revascularization^, 6), and
management of chronic obstructive pulmonary disease(7). This variation is not
significantly due to differences in appropriateness of care. (8) Part of this variation may
result from the level of uncertainty in medical decision making(9-l 1) and a lack of
consensus data for the standard of practice. When consensus data is available, there
remains a lack of dissemination and enforcement, which may lead to inappropriate and
costly care.(l 1) In an attempt to manage costs, the managed care movement has sought to
decrease variation in the delivery of health care through monitoring of providers and the
enforcement of existing consensus data.
1.3 Health Care Rationing
Rationing exists in the United States. Expressed in other words, beneficial
treatment is withheld from some and provided to others. (2, 3, l2-l4)Evidence of rationing
includes the queuing (first come, first serve)(15) systems in public hospitals, the
emergence of ultimatums for denying treatment to non-compliant psychiatric patients(16),
the lower likelihood of referral ofwomen and African-Americans for cardiac
catheterization 17), and the use ofDiagnosis Related Groups (DRGs) to obtain financial
reimbursement in the Medicare program.(l8, 19) Additionally, rationing by price (ability
to pay) is a frequently overlooked yet highly predominant rationing mechanism in the
United States.(20-22)
8Two primary rationing models exist. Resource-centered rationing ignores
differences between persons and focuses on features of the health services themselves,
e.g., cost. Patient-centered rationing identifies characteristics of the patient as criteria for
prioritization, e.g., age. Rationing mechanisms often have components of both. Table 1
summarizes mechanisms of rationing under each model.
Table 1.1 Rationing Mechanisms
Mechanism Definition Example
Resource-Centered
Capitation
Lifestyle
Market
Medical Benefit
Need
Self
Triage
Mixed
Silent
Limits amount ofmoney spent on a Medicare(23, 24)
particular population or set of services
Randomized clinical trials
Cost Cost of treatment determines availabili
Lottery Access to care determined by
randomization
Queuing First come, first serve
Patient-Centered
Cohort Rations to a particular group of people
or illnesses *
Degree of individual responsibility
determines eligibility for care
Price and ability to pay determines
access to costly services
Calculations determine who will receive
longest benefits from treatment
Care to the patient who needs it most
Individual expressions of desirability for
access to costly services
Probability of being "saved" determines
access
Physician discretion without patient's
knowledge
Waiting lines(25)
Oregon Plan(26-29)
Funding for AIDS therapy(30)
Alcohol abusers and liver
transplantation(3 1 )
Private insurance(32)
QALY(33-35)
Factoring in severity of illness or
number of dependents(34, 36)
Living wills(2)
Wartime
Trauma(37)
HMO "gag" rules
Withholding of psychotropic agents
(e.g., clozapine)( 1 6)
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Does rationing have to occur in the U.S.? Several trends in American medicine
point to the need for rationing. There has been little assessment of the social ramification
of technological innovations,(38-40) leading to unforeseen consequences. One such
consequence is the lack of financial resources to administer technology to everyone that
needs or demands it.(2)
Another trend is the escalation of health care costs without a concomitant
improvement in markers of health outcomes, such as infant mortality rate and life
expectancy.(4l) Moreover, Americans remain dissatisfied with their health care system
compared to other industrialized countries. (42) Health expenditures consumed close to
14% of the GDP in 1997(1), the largest percentage of all other industrialized countries.
Improvement in administrative efficiency(43) and capitation of doctors' salaries(44) do not
eliminate the necessity of rationing. Less than 25% of the nation's health dollar paid for
administrative and physician services, while hospital care consumed the greatest
percentage of resources (34%)(l). Thus, increasing health care costs coupled with health
care rationing creates the need to measure, analyze, and improve health care delivery,
particularly in the hospital setting.
1.4 Medical Errors andAdverse Events
Medical errors and adverse events are a significant component of medical
delivery. The recent Institute ofMedicine report (November 1999) has captured the
attention of the government.(45) The report claims that as many as 98,000 Americans
lose their lives each year as a result of preventable medical errors. (46) Up to 7,000 of
these people die because of errors in prescribing medicine. (46) In economic terms, the
cost of all these errors adds as much as $29 billion to medical bills. (46)
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The Harvard Medical Practice Study(47) was instrumental in characterizing the
nature of these errors and adverse events. In 1991, the researchers published data from a
random sample of 30,121 records in New York State in 1984. They defined an adverse
event as "an injury that was caused by medical management (rather than the underlying
disease) and that prolonged the hospitalization, produced a disability at the time of
discharge, or both." The researchers found that adverse events occurred in 3.7% of
hospitalizations. Of these events, 69% were preventable. Only 27.6% were clearly due
to negligence, but there was double the risk of negligence occurring in the elderly. Many
of these errors do not result in significant harm, and most of these errors are related to the
use ofmedication.(48, 49) For example, 22% of errors were due to the use of an
inappropriate drug. (49)
Though error does not equal negligence, there may be medicolegal consequences
to these errors. Negligence ("failure to meet the standard of practice of an average
qualified physician practicing in the specialty in question")(49) would occur when a
patient is given a drug despite a known sensitivity to it, resulting in an adverse event. (47)
Interestingly, negligent adverse events are more likely to occur in nonsurgical events than
surgical ones. (49)
The government is interested studying possible solutions to this problem.(50)
President Clinton recently approved funding for the investigation and reduction of
medical errors to improve the delivery of health care.(46) What follows is a discussion of
a paradigm for evaluating possible solutions.
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Part II: A Systems-Based Approach to Improving the Delivery of Medical Care
2.1 Precursors to Errors
An understanding of human cognition provides insight to possible solutions.
Errors often result from aberrations in mental functioning. (48, 51) Mechanisms of
cognitive errors include slips, mistakes, and latent errors. Slips are errors of action,
unconscious glitches in automatic activity. Mistakes are errors of conscious thought and
result from misapplied expertise. For example, the administration of a medication with
out appropriate indications represents a misuse of knowledge. Latent errors are failures
of design and organization that have delayed effects. One of the most important effects
of latent errors is the creation of pathologic situations in the workplace which predispose
to more errors. (52) This represents a problem in the process of health care delivery.
Using the previous example, the inappropriate use of a medication may also result from a
failure to effectively disseminate knowledge to clinicians in the workplace.
Thus, errors frequently are the cumulative result of a series of faults in a given
system. In the hospital setting, several structural issues in design predispose to a variety
of errors. (48) Physiological precursors include clinician fatigue, sleep deprivation.
habitual behaviors, and illness. Psychological factors include hurry, anxiety, boredom,
frustration, and frequent interruptions of staff. While not necessarily significant
contributors to harmful errors, these factors compound other faults in the system.
2.2 Computerized Decision Aids in Error Prevention
Many have pointed to the need for a systems-based approach.(9, 46, 49, 50, 52, 53)
Error prevention requires buffers in the system, and improvements are best made in the
workplace by improving working conditions. Error prevention results from designing
13
tasks and processes that minimize dependency on weak cognitive functions, such as
short-term memory. (54)
Computerized decision aids are an important mechanism to reduce and prevent
medical errors. (48) Several characteristics of electronic aids render them effective. First,
electronic aids reduce reliance on memory (e.g., reminders of drug allergies and adverse
reactions). Second, aids improve access to information (e.g., reminders of drug
interactions and indications). Third, with proper design, aids can assist in error proofing
(e.g., critical tasks can be structured so that errors cannot be made). An example of this
type of forcing function is a program prohibiting a clinician to order lethal doses of a
medication.
The Clinical Care Support System (CCSS) at Yale-New Haven Hospital (YNHH)
is an example of a mechanism that can be used for error prevention. CCSS is the
computer system that clinicians use to enter orders and retrieve data on their patients. As
a physician-order-entry system, CCSS potentially reduces adverse events by simplifying
and standardizing the ordering process. As previously mentioned, injuries due to drugs
were the most frequent cause of adverse events in the Harvard Medical Practice
Study. (55)
There is evidence to show that most injuries can be prevented using a physician-
order-entry system. (55) The system is able to intercept errors and provide an intervention
at the time the time the order is written. A 1994 study at Beth Israel Hospital (Boston,
MA) concluded that computer-based alerts for inpatients reduced adverse events
primarily because they are generated in real time. (56) The target of the system was the
physician in most cases. Bates demonstrated that physicians are responsible for 81% of
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medication errors other than missed doses. (55) Thus, a system targeting the physicians at
the time of decision making has a high yield.
Designing order sets within an electronic system further refines the error
reduction process. Order sets refer to a series of patient orders clustered together by
diagnosis or procedure. These can be used to identify patients at risk for errors prior to
entering an order. (49) Additionally, order sets can improve adherence to critical pathways
in an inpatient setting. (57) Hence, computer-generated reminders can reduce clinical
errors in the management of simple clinical events.
A study by McDonald in the 1970s showed that physicians detected and
responded to twice as many events when given computer recommendations as when
not. (58) This was independent of the physicians' number of years of training. Thus,
computer reminders can improve physician compliance with predefined care protocols.
A subsequent McDonald study confirmed that a computer reminder messages reduce the
disparity between the actions and intentions of house staff.(59) An important corollary is
that computer reminders are most effective when targeted towards aligning physician
intentions and actions, i.e., reminding physicians of doing something they intended to do
regardless.
In 1993, Tierney demonstrated that a network ofmicrocomputer workstations
(including an electronic medical record) for writing all inpatient orders significantly
lowered patient charges and hospital costs (up to $3 million in charges annually for the
medicine service)(60). The researchers believe the strengths of such a system is in
"counter detailing," e.g., recommendations not to use specific drugs in certain
circumstances, as well as in providing patient-specific information at the point of
15
decision making. The pharmaceutical industry has employed detailing methods as their
primary method of product dissemination with much success.
2.3 A Needfor Further Research
Previous evidence supports the use of electronic order entry systems in affecting
physician practice patterns, but with a few exceptions, these were mostly in an outpatient
setting (e.g., reminders for annual mammograms, colonoscopy, etc.). As mentioned
earlier, efforts at quality improvement should additionally target the inpatient setting,
where more than half of all health care dollars are spent. (60) Communication and
information management consume as much as 40% of all inpatient costs(60) and yet the
potential for adverse events remains high. Further data is needed from an inpatient
setting specifically evaluating adverse patient outcomes. The goal of this work is to
contribute data in this important area.
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Statement of Purpose and Hypothesis
Part III: Theoretical Basis of the Study
3.1 Statement ofPurpose
1 . To determine the effect of a Clinical Care Support System (CCSS) electronic
reminder screen on physician's use of diphenhydramine (Benadryl) as a
pretreatment prior to blood transfusions.
2. To identify and provide insight into the variability in the response rate of physicians
to this reminder.
3. To suggest changes in computer-generated reminders that may lead to improvements
in patient outcomes.
3.2 Hypothesis
The hypothesis to be tested is that the presence ofan electronic reminder screen
reduces the inappropriate use ofdiphenhydramine as a pretreatment prior to blood
transfusions.
The reminder screen specifically alerts the physician as to the appropriate
indications for diphenhydramine and then asks if the physician would like to continue
ordering the medication. The screen relies on the physician to assess whether the patient
has indications for pretreatment and to proceed accordingly.
A secondary hypotheses is that a decreased use ofdiphenhydramine as a
pretreatment reduces the occurrence ofmental status change in hospitalizedpatients.
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3.3 Principles of Total Quality Management
The use of total quality management (TQM) in health care has increased
dramatically in recent years.(6l) The focus is on systemic causes of quality problems
rather than on individual ones. TQM is intended to identify problems and/or
inappropriate variations in the health care process and system of care as well as to work
continuously to eliminate those problems at all levels of the organization. The structure
of this study focuses on the second of three basic techniques(62) of TQM: 1) quality
improvement (QI); 2) quality planning (QP); and 3) quality control. The QI approach
(completed prior to this work) consists of a rigorous evaluation to clarify identified
problems in the process of health care delivery. In this study, the identified problem is
the inappropriate use of diphenhydramine as a pretreatment for blood transfusions
leading to an increase in adverse events and cognitive decline.
The QP approach evaluates an existing process and focuses on meeting the needs
of external customers (patients) and suppliers (clinicians). The process is analyzed for
potential problems that may lead to deviations from the intended process (in this case, the
inappropriate prescription of diphenhydramine). Therefore, this study provides an
analysis of the rate and reasons for non-adherence to a specific computer-generated
reminder in the CCSS system at Yale-New Haven Hospital. In line with a QP approach,
the study seeks to identify the root causes of non-adherence to the reminder as a means to
select, evaluate, and implement possible solutions.
3.4 Clinical Background
Allergic reactions occur in 1 to 2% of blood transfusions. (63) These are
characterized by urticaria, edema, headache, and dizziness. (64) This may be the most
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frequent adverse effect of transfusions, and is more likely to result from red cells that
have been stored a prolonged period of time. The mechanism of reaction may result from
cytokines that accumulate in blood unless white blood cells (WBC) are removed.
Histamine levels also increase during storage. Plasma proteins in transfused components
may trigger the reaction. (64)
Management of allergic transfusion reactions is symptomatic. Antihistamines
have been shown to be effective when added to donor blood. (65) However, the primary
treatment is administration of diphenhydramine once symptoms emerge. The clinician
temporarily stops the transfusion, gives diphenhydramine (50mg IM/PO), and then
restarts the transfusion when symptoms begin to resolve (approximately 30 min).
Premedication with diphenhydramine should only occur in those with a history of allergic
transfusion reactions(64-66) and in high risk populations (e.g., previously transfused
patients, multiparous women(67)) at the discretion of the physician.
A previous study of over 400 patients at Yale-New Haven Hospital examined the
use of diphenhydramine in older hospitalized patients (Agostini, J.V., Leo-Summers,
L.S., Inouye, S.K. Diphenhydramine in Hospitalized Elderly. AGS/AFAR 2000 Annual
Scientific Meeting (Abstract)). Cognitive decline occurred in 83/423 (26%) of the
diphenhydramine group versus 17% in the untreated group (RR 1.5, CI 1.0-2.2). Other
significant changes (p < 0.05) included higher rates of inattention (13% vs. 5%),
disorganized speech (4% vs. 1%), lethargy (13% vs. 5%), and inappropriate behavior (4%
vs. 1%). Twenty percent of the 222 treated patients received diphenhydramine as a
pretreatment for blood transfusions. None (0/44) had an appropriate indication. The
researchers concluded that the use of diphenhydramine required reexamination to reduce
iatrogenic complications such as cognitive decline.
3.5 Electronic Reminder in CCSS
Figure 3.1 is a process diagram depicting the point at which the screen appears
during the ordering process. Figures 3.2 and 3.3 portray the actual screen menu and
reminder in CCSS, respectively. The electronic reminder seeks to target physicians in the
following situations:
1. Physicians who are not aware of the appropriate indications for
diphenhydramine as a pretreatment for blood transfusions.
2. Physicians who are aware butfail to recall the appropriate indications.
3. Physicians who are aware and recall the appropriate indications, but
fail to carry out intended action to withhold diphenhydramine.
Figure 3.1 Process Diagram for Electronic Reminder
Select desired
patient from list
Select
diphenhydramine
pretreatment
option if desired
Select Blood Bank
option from menu
Order desired type
and amount of
transfusion
(:. Appearance| of electronicreminder Continuation/discontinuationof diphenhydramine order
Figure 3.2 Portion of Transfusion Menu in CCSS
B ) TRANSFUSE OPTIONS
CBC H AFTER TRANSFUSION
PLATELET CT H AFTER TRANSFUSION
PT H AFTER TRANSFUSION
PT-COUMADIN
PT
?OTHER POST TRANSFUSION LABS
?OTHER LABS
TYLENOL 650MG PO 30MIN BEFORE TRANS
TYLENOL LIQ MG, PO 30MIN BEFORE
?ORDER BENADRYL
?OTHER TYLENOL ? OTHER LAS IX ?OTHER BB
reen^jFigure 3.3 Electronic Reminder Screen
os ;> DIPHENHYDRAMINE USE IN
TR ANSFUS IONS
DO YOU STILL NANT TO ORDER BENADRYL:
?NO ?YES
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3.6 Health Care Setting
Yale-New Haven Hospital is a 900-bed acute care facility that functions as a
general community hospital, private hospital, and tertiary care referral center in New
Haven, Connecticut, USA. It is an academic medical center and is the primary teaching
hospital of the Yale University School of Medicine. Its patient care mission is to provide
sensitive, high quality, and cost effective health care services to all patients, regardless of
ability to pay. The hospital also has a mission of teaching the medical and allied health
professions, pursuing ongoing clinical research, and promoting community service
through public health advocacy.
5. 7 Measurement Characteristics
The focus of the measurement is to evaluate the use of diphenhydramine as a
pretreatment for blood transfusions. The purpose of the measurement is to obtain
baseline information for internal quality improvement. The target of the evaluation is the
physician house staff, as the end-users of CCSS and the persons most involved in
generating the day-to-day ordering ofmedications and therapy. As previously
mentioned, targeting physicians is a high yield strategy. The major sources of data
include the YNHH Blood Bank, patient medical records, and a follow-up survey
administered to the house staff.
3.8 Constraints
The primary constraints are threefold in nature financial, clinical, and logistical.
Financial considerations restrict the number of records to review and the number of house
staff to survey. Clinical constraints stem from physicians' reluctance and/or inability to
cooperate with the measurement effort. Physicians may fear retribution if medication
errors or other clinical errors are found. Additionally, physicians may not agree with
consensus-based clinical guidelines regarding the appropriate pretreatment of their
patients.
Logistical constraints pose a problem of validity. House staffmay use another
electronic pathway with which to order pretreatment medications that does not trigger the
reminder screen. Hence the screen intervention would not target the complete audience.
Another logistical constraint is that house staff are not the ultimate decision makers in the
care of their patients, and ordering of diphenhydramine may reflect attending physician
practice patterns rather than house staff, the actual targets of the screen intervention.
3.9 Benefits ofMeasurement Collection
Advantages to conducting the evaluation at this particular point in time include
locally addressing the recent national concerns regarding patient safety and medical
errors by decreasing inappropriate prescribing of diphenhydramine. Secondly, the study
evaluates the use of CCSS as a tool to both measure and implement this quality
improvement mechanism, an important endeavor in the context of increasing financial
pressures associated with rising pharmacy and hospital costs.
3.10 Strengths ofMeasurement
The diphenhydramine pretreatment reminder is an ideal choice because it meets
several evaluation criteria outlined elsewhere(62) for quality measurement. It is a focused
measure addressing a simple clinical event, and multiple clinical services utilize the
electronic pathway. Additionally, for the bulk of clinical services, CCSS allows virtually
no other method for ordering blood and diphenhydramine, increasing the validity of the
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measurement. The exceptions are the oncologic services in medicine and gynecology,
which have access to a separate pathway that allows for ordering diphenhydramine
without triggering the electronic reminder.
Because the electronic reminder is at the point of decision making, it has the
potential to shape physician education and the quality of patient care. It provides
information in a relevant and timely fashion at the time physicians put medical decisions
into action, and this method of quality improvement may be a model for other
interventions in the health care setting. From a clinical standpoint, the issue of
inappropriate prescription of diphenhydramine addresses potentially preventable
outcomes and prevention of medication-induced comorbidities. The issue is also
financially important to YNHH. While diphenhydramine itself is not a costly drug,
complications from inappropriate use can lead to the utilization ofmore services (e.g.,
medications, nursing time, restraints, imaging) and also to longer lengths of stay.
The electronic reminder is well-suited for evaluating the inpatient setting, and
thus is appropriate for internal quality assessment. Measurement is feasible given
resource constraints and data availability. The study is useful for implementing cost
savings and improving patient care. Additionally, clinicians receive valuable feedback.
The electronic reminder is evidence-based. Finally, the measurement incorporates
process and short-term outcomes within the hospital setting.
Overall, this study aims to provide data evaluating the effectiveness of this
particular transfusion order set in CCSS. Since no data of this sort currently exists, this
information will provide a basis for current quality measurements and future efforts in
quality control. This endeavor stands to provide information at minimal risk to patients
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that can ultimately impact the quality ofmedical care given at Yale-New Haven Hospital.
Additionally, this same methodology can be used to evaluate other CCSS interventions
such that the computer system can be refined to better reduce medical errors and improve
patient safety.
Methods
Part IV: Evaluation of Reminder Response Rate
4. 1 Time Period Selection
The intervention (electronic reminder screen) was added to CCSS system on July
21, 1998. The time periods selected include 4/1/98 to 4/30/98 (pre-screen group), 8/1/98
to 8/31/98 (post-screen group), and 8/1/99 to 9/31/99 (post-screen comparison group).
The extra month within this time period ensured a comparable number of transfusion
episodes to the pre- and post-screen groups. This time period compared the results of the
intervention one year after implementation and with the addition of a new cohort of house
staff.
4.2 Sample Size Selection
The sample unit was one transfusion episode. Operationally, the definition of a
transfusion episode was a computer order of one or more consecutive units of red blood
cells (RBC). The number of transfusion episodes needed in each time period for alpha =
0.05 (two-tailed) and 80% power was at least 173 episodes. (68) This was based on the
estimate that approximately 60% of transfusion patients were receiving diphenhydramine
prior to the implementation of the screen and 40% were receiving it after. With this
sample size, the study has 80% power to detect at least a 1 5% difference in rates of
diphenhydramine use.
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4.3 Subject Population
The sample consists of adult patients (greater than 1 8 years of age) who received
at least one unit of RBCs within each time period while an inpatient on a medical or
surgical service at Yale-New Haven Hospital. The patients were chosen consecutively
from a list of RBC recipients during each time period from a list generated by the YNHH
Blood Bank. If patients received more than one transfusion during their stay, each
computer order was counted as a transfusion episode. Because the goal of the study is to
evaluate the effectiveness of the CCSS screen as an intervention, the researchers believe
that each computer order entry should be included as a separate data point in the study.
Additionally, since multiple house staffmay enter orders on the same patient, this method
ensures that each viewing of the screen is included in the study.
4.4 Data Collection andAnalysis
The YNHH Blood Bank provided list of patients receiving a transfusion of any
type during the selected periods, totaling 1,703 patients. Exclusion criteria included
transfusion episodes of blood products other than RBCs, such as leukoreduced RBCs,
fresh frozen plasma (FFP), and platelets. This reduced the number of eligible patients to
1,086. Charts were additionally excluded if crucial data sources were missing, such as
progress notes or computer order summaries. A total of 784 records were requested,
yielding 752 transfusion episodes (from 467 patients) for review. Of these 253 were in
the pre-screen group, 249 in the post-screen group, and 250 in the post-screen
comparison group.
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Figure 4.1 depicts the process of data extraction. After receiving a list of patients
transfused during each time period, a review of patient medical records supplied the
following data:
1 . Was the transfusion episode accompanied by diphenhydramine as a
specific pretreatment?
NOTE: as documented by the computer order entry record and
medication record.
2. Was documentation present ofan indication for its use?
NOTE: These included a history of allergic transfusion reaction (as
stated in past medical history or progress note), history ofmultiple
transfusions (as stated in past medical history), and/or multiparous
state (documentation of 2 or more births).
3 . Was documentation present ofa mental status change within 72 hours
of the transfusion episode?
NOTE: as documented in a progress note using any combination of
words including: "agitation"; "bizarre behavior"; "change in mental
status"; "combativeness"; "confusion"; "delirium"; "disorientation";
and "lethargy."
Microsoft Excel 1 997 was the software program housing the raw data. Chi square
analysis evaluated the categorical variables. Hospital administrative data stored on
Microsoft Access provided the age and primary and secondary discharge diagnoses of
each patient included in the study.
Figure 4.1 Data Extraction Flowchart
( Start )
Patient
received an
RBC
transfusion?
YES
Patient ordered
diphenhydramine
prior to
transfusion?
YES
Indication present
for
diphenhydramine?
YES
Was there a diagnosis
ofmental status
change after the
transfusion episode?
YES
( Stop j
NO
/ Stop j
Classification = MED
Classification = IND
Classification = DX
Classification = Not
Reviewable
Classification = NOMED
Classification = NOIND
Classification = NODX
End of Review
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Part V: Follow-Up Survey with House Staff
5.1 Description
The second component of data collection involved a self-administered follow-up
questionnaire. The purpose was to investigate clinician opinion regarding the
diphenhydramine reminder in CCSS. Figure 5.1 illustrates the actual 2-page survey.
This component of data collection asks questions evaluating the reminder based on
guidelines(62) for reminder design. In doing so, the survey addresses the following
issues:
1 . Are YNNH clinicians aware of the current indications for
diphenhydramine pretreatment prior to a transfusion?
2. Have the clinicians ever encountered the electronic reminder? If so,
what have their reasons been for overriding/not overriding it?
3. Do the clinicians find the reminder helpful?
5.2 Subject Population
The subjects were house staff from the medical and surgical services at YNHH
during the month ofMarch, 2000. Exclusion criteria included medical student or
attending physician status to focus the research on the clinicians most directly involved in
entering daily patient orders.
5.3 Data Collection andAnalysis
The respondents received the surveys either while at attendance at mandatory
conferences, or through their program administrators. Microsoft Excel 1997 housed the
data and provided descriptive statistics.
Figure 5.1 House StaffQuestionnaire
Dear Colleague,
The researchers are conducting a study assessing the effectiveness of electronic reminders in the Clinical
Care Support System (CCSS) to improve patient care at Yale-New Haven Hospital. CCSS is the electronic
system with which you enter orders for inpatients on patient care floors. This survey instrument is intended
to assess your opinions regarding the software's effectiveness in improving the ordering of blood
transfusions. Your responses are anonymous, and your participation is voluntary. The questions that
follow will in no way be utilized to identify you. As the main users of the system, your input is critical to
the success and further improvement ofCCSS and its use in patient care, and the researchers sincerely
appreciate your participation.
Thank you,
Dr. Victor Morris
Alicia Arbaje, YMS V
1) How often do you use the Blood Bank Index in CCSS to order blood (i.e., selecting "Blood Bank"
under Master Guide)? (circle one)
0-25% of the time 26-50% of the time 5 1-75% of the time 75-99% of the time 100%of the time
2) How often do you order Benadryl as a pretreatment for your patients prior to receiving blood? (circle
one)
0-25% of the time 26-50% of the time 5 1-75% of the time 75-99%of the time 100%of the time
3) Are you aware of the blood banks recommendation not to use Benadryl as a pretreatment except when
there is a prior history of allergic reactions, multiple transfusions, or multiparous state (circle one)?
YES NO
4) Have you seen the screen on CCSS reminding you of this recommendation (circle one, see example of
screen below)?
YES NO
\ /
Diphenhydramine in Transfusions
Routine use of the diphenhydramine (Benadryl) is not routinely indicated for premedication prior to blood
transfusion. Patients with multiple previous transfusions, multiparous women, and patients with a prior
history of an allergic transfusion reaction should be premedicated with an antihistamine such as
diphenhydramine. Also, antihistamines can cause delirium and other adverse reactions in elderly patients.
Do you still want to order Benadryl? YES NO
/ \
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5) Have you ever seen the screen and continued to order Benadryl (circle one)?
YES NO N/A
If yes, why?
If no, why?
6) Please choose the statement that most closely reflects your feelings about this reminder on CCSS:
I find it helpful and would like to see it continue on CCSS
I find it helpful but would not like it to remain on CCSS
I find it annoying but would like to see it continue on CCSS
I find it annoying and would not like it to remain on CCSS
7) Please choose the statement that most closely reflects your familiarity with the CCSS system:
I struggle on a daily basis to find the orders I want
I sometimes have difficulty finding the orders I want
I hardly ever struggle to find the orders I want
What level are you in training (circle one)? PGY-I PGY-II PGY-III PGY -IV PGY-V Beyond
Was there an electronic order entry system at your prior institution? YES NO
In what residency program are you (circle one)?
Internal Medicine
General Surgery
Anesthesiology
Emergency Medicine
Dermatology
Psychiatry
Radiology
Neurology
Surgical Subspecialty (please state)
Fellowship (please state)
Thank you for your participation in this study.
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Results
Part VI: Retrospective Chart Review
6.1 Overall Effects of the Electronic Reminder on Diphenhydramine Use
This researcher retrospectively reviewed a total number of 752 transfusion
episodes, with 253 in the pre-screen group, 249 in the post-screen group, and 250 in the
post-screen comparison group. The mean age in each group was 66 years (SD = 15), 64
years (SD = 15), and 69 years (SD = 12), respectively, and these represented a total of
467 patients, as some patients had multiple orders for transfusions over the selected time
periods. Tables 6.1 and 6.2 list the principal and secondary discharge diagnoses for 408
of the 467 patients (no matches found for 59 patients on the administrative database
system due to misfiling). Figure 6.1 presents the number of diphenhydramine orders in
each time period. Figures 6.2, 6.3, and 6.4 portray the percentage of transfusion episodes
accompanied by a diphenhydramine pretreatment order in each time period 103/253
(41%) in the pre-screen group, 49/249 (20%) in the post-screen group, and 29/250 (12%)
one year later. There was a statistically significant reduction in the ordering of
diphenhydramine from the pre-screen to the post-screen comparison group (p < 0.005).
Table 6.1 Primary Discharge Diagnoses of Patients in Each Time Period
Primary Diagnosis Pre Post 1 Year
Anemia 5 (3.5%) 3(1.1%) 2 (0.8%;i
CAD/MI 16(11.2%) 11(3.9%) 29 (22.7%)
Congestive Heart Failure 7 (4.9%) 6(2.1%) 3 (2.3%)
Diabetes Mellitus 4 (2.8%) 5(1.8%) 1 (0.8%)
Empyema 1 (0.7%) 0 (0.0%) 1 (0.8%)
Fracture 10(7.0%) 3(1.1%) 3 (2.3%)
HIV 2(1.4%) 5(1.8%) 1 (0.8%)
Malignancy 13(9.1%) 15(5.4%) 13(10.2%)
Osteoarthritis 6 (4.2%) 6(2.1%) 6 (4.7%)
Pneumonia 3(2.1%) 3(1.1%) 1 (0.8%)
Post-Op Infection 1 ( 0.7%) 3(1.1%) 2 (0.8%)
Pulmonary Embolism 1 (0.7%) 1 (0.4%) 1 (0.8%)
Renal Failure 3(2.1%) 2 (0.7%) 3 (2.3%)
Respiratory Failure 1 (0.7%) 1 (0.4%) 0 (0.0%)
Septicemia 3(2.1%) 3(1.1%) 1 (0.8%)
Urinary Tract Infection 1 (0.7%) 3(1.1%) 1 (0.8%)
Other 66 (46.2%) 67 (23.9%) 60 (46.9%;)
Total 143 137 126
Table 6.2 Secondary Diagnoses of Patients in Each Time Period
Secondary Diagnosis Pre 130St 1 Year
Anemia 67 87 73
Atrial Fibrillation 34 48 47
CAD/MI 120 63 125
Congestive Heart Failure 45 37 32
Deep Venous Thrombosis 0 0 10
Diabetes Mellitus 42 49 39
History of Malignancy 43 34 18
Hypertension 62 42 82
Hypothyroidism 15 7 13
Hypovolemia 19 10 9
Malignancy 13 7 23
Pneumonia 26 13 36
Pulmonary Embolism 1 0 2
Respiratory Failure 19 14 11
Septicemia 12 20 17
Urinary Tract Infection 24 15 18
Figure 6.1 Number ofDiphenhydramine Orders Prior to Transfusion
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Figure 6.3 Distribution ofDiphenhydramine Pretreatment Orders in the Post-
Screen Group
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Figure 6.4 Distribution of the Diphenhydramine Pretreatment Orders in the Post-
Screen Comparison Group
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6.2 Subgroup Analysis by Service
A total of 14 different clinical services comprised the data pool. The distribution
of services within each time period is similar (Table 6.3). The subgroup analysis focused
on the medical, surgical, and obstetrics and gynecology (Ob/Gyn) services. Table 6.4
depicts the number of diphenhydramine orders by service within each time period. All
services reduced their use of diphenhydramine after screen implementation (Figure 6.4).
The largest reduction of diphenhydramine use was in the medical services (Table 6.5).
This represents the absolute percentage point reduction over the selected time periods.
Values in Tables 6.4 and 6.5 reflect the percentage within each service, not within the
total population. This represents a statistically significant association between
diphenhydramine orders among services since the implementation of the screen (p value
= 0.02).
Table 6.3 Distribution of Clinical Services in Each Time Period
Service Pre-Screen Post-Screen 1 Year Post Total # in Study
Internal Medicine 40.7% 44.2% 34.8% 300
General Surgery 17.0% 13.7% 17.2% 120
Cardiothoracic Surgery 12.6% 12.0% 20.4% 113
Orthopedic Surgery 16.6% 15.3% 7.2% 98
Gynecology 6.3% 5.2% 6.0% 44
Unknown 0.8% 1.2% 5.2% 18
Neurosurgery 1.6% 0.4% 4.4% 16
Ear, Nose, Throat Surgery 0.8% 2.8% 2.0% 14
Urology 1.2% 2.8% 1.2% 13
Neurology 1.2% 1.2% 0.4% 7
Obstetrics 1.2% 0.8% 0.0% 5
Plastic Surgery 0.0% 0.4% 0.4% 2
Pediatrics* 0.0% 0.0% 0.4% 1
Pediatric Surgery* 0.0% 0.0% 0.4% 1
Total 100.0% 100.0% 100.0% 752
*Note: Patients included were over 1 8 years of age.
Table 6.4 Number ofDiphenhydramine Orders by Service*
AllMedical 48(45.3%) 25(22.1%) 6(6.7%)
All Surgical 43(34.1%) 13(11.1%) 12(9.0%)
Ob/Gyn 11(57.9%) 8(53.3%) 8(53.3%)
*Note: Values reflect percentages within each service, not within the total population.
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Table 6.5 Absolute Percentage Point Reduction in Diphenhydramine Use Over All
Time Periods*
Service Pre to Post-Screen Post to 1 Yr. Post-Screen Overall
AllMedical -23.2% -15.4% -38.6%
All Surgical -61.6% -2.1% -25.1%
Ob/Gyn -4.6% 0.0% -4.6%
"Note: Values reflect percentages within each service, not within the total population.
6.3 Appropriateness ofDiphenhydramine Use
While actual rates of diphenhydramine use are informative, a measurement of
appropriate use is more clinically important. The presence or absence of an indication
for the medication's use drives the determination of appropriateness. Figure 6.5
demonstrates the percentage of transfusion episodes that had a documented indication
present (n = 86). There was a statistically significant association between the presence of
an indication and the use ofdiphenhydramine (p = 0.01). Figures 6.6 and 6.7 present the
percentage of the treated (n = 181) and untreated (n = 571) group with a documented
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indication, respectively. Note, however, that only 30/181 (17%) of the treated group
actually had a documented indication for diphenhydramine.
Figure 6.5 Percentage of Transfusions with a Documented Indication
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Figure 6.7 Percentage of Untreated Group with a Documented Indication
6.4 Effects ofDiphenhydramine Use on Patient Outcome
This portion of the study sought to assess whether increased diphenhydramine use
was associated with an increase in mental status changes. Figures 6.8 and 6.9 present the
percentage of episodes associated with a mental status change in both untreated (n = 472)
and treated (n - 124) groups, respectively. Of those with a mental status change, Figures
6.10 demonstrates the distribution ofdiphenhydramine use (n = 83). Figure 6.1 1 shows
the same information in the non-mental status change group (n = 513). Note that the use
ofdiphenhydramine was associated with a higher percentage ofmental status change than
the non-diphenhydramine group 32/83 (39%) versus 92/513 (18%). This represents a
statistically significant association between diphenhydramine use and mental status
change (p < 0.0005). The most common symptoms noted were lethargy, confusion,
agitation, and combativeness.
Figure 6.8 Percentage of Episodes Associated with Mental Status Change in the
Untreated Group
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Figure 6.10 Distribution ofDiphenhydramine (DPH) Use in those with Mental
Status Changes
Figure 6.11 Distribution ofDiphenhydramine (DPH)Use in those without Mental
Status Changes
DPH
18%
Part VII: Follow-Up Survey
7. 1 Subject Population
A total number of 56 house staff completed the survey (estimated response rate
56/105, or 53%>). While the actual number of surveys distributed to the medicine house
staff is not known, an estimation of the response rate yields 43/80 (54%) including 2
emergency medicine residents and 1 medicine/pediatrics resident. This is based on the
number ofhouse staffwho likely attended 2 different intern reports and 2 different
resident reports. Eight orthopedic surgery residents responded out of 20 (40%>). Five out
of five (100%>) responded from the general surgery house staff. The majority of the data
came from the departments of internal medicine and orthopedic surgery (71%> and 14%,
respectively). Table 7.1 describes the distribution of clinical services in the survey
population. Most respondents were in their first or second year of training (38%) and 34%>,
respectively). Figure 7.1 portrays the distribution of respondents' level of training. The
majority of residents did not come from an institution using electronic order entry (62%,
see Figure 7.2).
Table 7.1 Distribution ofClinical Services in the Survey Population (n=56)
Number Percentage
Internal Medicine 40 71%
Orthopedic Surgery 8 14%
General Surgery 5 9%
Emergency Medicine 2 4%
Medicine/Pediatrics 1 2%
total
'
56 100%
Figure 7.1 Respondent Level of Training
PGY 1 PGY 2 PGY 3 Beyond
Figure 7.2 Experience with Electronic Order Entry
Was There an Electronic Order Entry
System atYour Prior Institution?
7.2 House StaffResponses
The first question asked how often the respondents utilize the "Blood Bank
Index" in CCSS to order blood. As stated earlier, this is the pathway in which the screen
appears. Seventy eight percent of the respondents said they used this electronic order
pathway 100% of the time (Figure 7.3). The second largest group (13%) reported using
the pathway 76-99% of the time (SD = 0.9).
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Question 2 asked how often the respondents ordered diphenhydramine as a
pretreatment prior to receiving blood. The vast majority (Figure 7.4) reported ordering
diphenhydramine 0-25% of the time (69%) or 26-50% of the time (16%, SD = 0.9). The
majority (71%, SD = 0.5) of the respondents were aware of the blood bank's
recommendation not to routinely use diphenhydramine as a pretreatment (Figure 7.5).
Figure 7.3 Distribution ofRespondents Using the Blood Bank Index
Do You Use the Blood Bank Index?
0-25% 26-50% 51-75% 76-99% 100%
Frequency of Use
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Figure 7.4 Distribution ofRespondents Pretreating Transfusion Patients
Do You Pretreat Your Patients?
Frequency of Use
Figure 7.5 Awareness of Blood Bank Recommendation
The next part of the questionnaire sought to evaluate the number of respondents
who had seen the electronic reminder. Figure 7.6 demonstrates that 55% of the
respondents reported having seen the electronic reminder (SD = 0.5). The follow up
question assessed how many had changed their behavior because of the reminder. Fifty
nine percent (SD = 0.7) of the respondents reported that they did not order
diphenhydramine after seeing the screen, presuming indications were not present (Figure
7.7). Table 7.2 portrays resident commentary regarding their individual decisions.
Figure 7.6 Proportion of Respondents Reporting Seeing the Electronic Reminder
Have You Seen the Screen?
^^^/ ^^r 55%
Figure 7.7 Proportion of Respondents Changing their Behavior due to the
Electronic Reminder
Have You Seen the Screen and
Continued to Order Benadryl?
Yes
4,S
Table 7.2 Commonly Stated Reasons for Individual Prescribing Pattern
Reasons to Continue Ordering
Diphenhydramine
History of transfusion reaction
History of allergic transfusion reaction
History of allergies
History of febrile reaction
Reasons Not to Order Diphenhydramine
Side effects outweigh any potential benefit
Patient did not need medication
Tylenol is a sufficient pretreatment
Agreement with blood bank recommendations
Screen not present during early part of training "Benadryl is overused"
"That's what I learned in medical school"
"The nurse made me do it."
"I always have ordered it, so I continue to do so."
"Never had a problem with using it before."
The survey then evaluated whether the respondents found the reminder helpful
and whether it should remain in CCSS. Sixty five percent found the reminder helpful and
felt it should stay in the system (Figure 7.8). Eleven percent found it helpful, but thought
the reminder should be omitted from the system. Twenty percent found the reminder
annoying but nonetheless thought it should stay. Finally, 2%> found the reminder
annoying and thought it should be removed from the system (SD = 0.9).
To assess the familiarity of the respondents with the CCSS, Question 7 asked how
often they struggled with the computer system. Most struggled some of the time (49%o)
or hardly ever (47%>). However, several residents stated that this level of familiarity
came after a long period of adjustment to a "poorly designed, non-intuitive system."
Figure 7.9 represents the distribution of responses to Question 7 (SD = 0.6).
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Figure 7.8 Respondent Opinion Regarding the Usefulness of the Reminder
Should the Reminder Stay?
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Figure 7.9 Respondent Familiarity with CCSS
How Often Do You Struggle with CCSS?
Daily
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Discussion
Part VIII: Electronic Reminders and Physician Practice Patterns
8.1 Characteristics ofEffective Reminders
This study confirms what others have shown(55-60) regarding the effectiveness of
electronic reminders in impacting physician practice patterns. Moreover, the study
comes from an inpatient setting, an area in which there has been less research. The data
in this study points to a significant reduction in diphenhydramine use as a pretreatment to
blood transfusions since the implementation of the electronic reminder. The overall
reduction (41% to 20% diphenhydramine use) not only persisted over time, but it actually
became more pronounced 1 year later (additional reduction from 20% to 12%
diphenhydramine use).
If not supported by the leadership of the institution, many alterations in clinician
behavior patterns extinguish over time.(6l, 69, 70) Physicians must perceive a need for
behavior change, and they must see key opinion leaders (e.g., fellow house staff, faculty)
altering their practices. The electronic reminder serves to present the need for change
(citing the increased delirium associated with diphenhydramine use). The persistent
reduction in the rate of use suggests that the interns who first saw the screen in 1998
continued to practice in concordance with the appropriate indications as residents, and the
new interns in 1999 adopted the guideline into their ordering practices. The reminder
combined with the perceiving the altered behavior in junior and senior residents likely
further influenced the incoming interns.
The success of the reminder may have been due to other factors as well.
Generally, there is poor dissemination of clinically relevant information in a form that is
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useful to the practicing physician. (69) The screen was placed at the most common.
practically universal, pathway for the ordering of blood. Thus, it had a large audience
base, impacting most clinical services. It was present at the point of decision making.
and it provided a clinical rationale in addition to an alert. Hence, the reminder served a
more persuasive, educational role with each cohort of house staff.
The educational role is particularly important in the graduate training phase of
medical education, where the individual, especially the intern, is undergoing a process of
socialization. The house officer first encounters a new social setting or culture and must
learn to interact successfully with members of that culture by adopting or becoming
sensitized to their practices, behaviors, and language.(6l) Doctors are sensitive to
information indicating that the quality of their care is questionable or outside the norm.
Thus, an electronic reminder can be instrumental in disseminating institutional practices
at a time when the recipient of the information is likely to adopt new practices.
Successful guidelines are specific, and they clearly define the indications for a
test or procedure that is inappropriate as well as for one that is appropriate. (69) They are
comprehensive, including all likely indications for the use of the therapy. This reminder
was specific, comprehensive, and most importantly, it was integrated into the decision
making process of the physician in her or his daily practice. The practice change was
manageable, making the reminder useful. The reminder in this study was for a simple
clinical event with straightforward indications. The indications for appropriate
diphenhydramine use apply to patients on any service, regardless of age and associated
comorbidities, therefore risk adjustment of patient populations would not likely influence
the results.
Exceptions to the above are the oncologic services for several reasons. Particular
chemotherapy order sets allow the clinician to order blood through alternate pathways
that do not activate the electronic reminder. Additionally, many chemotherapy patients
are recipients ofmultiple transfusions, and the indications for diphenhydramine are more
easily met. This may explain why a smaller reduction in diphenhydramine use occurred
in the Ob/Gyn service. This group includes the gynecologic oncology patients, and the
individual contribution of the increased use came from the gynecology service. Even
after screen implementation, over half of the transfusion episodes were accompanied by
diphenhydramine orders, unlike the medical and surgical services. Additionally, the
medical services had a slower decline in diphenhydramine use than the surgical services.
That is, the interim reduction in diphenhydramine use from the 1st time period to the 2"
was less dramatic in the medical services. Those residents on the medical oncology
service may have contributed to this slower decline.
There are many well-known barriers to physician compliance with clinical
guidelines. (69, 71) Physicians may perceive the guideline to be a threat to physician
autonomy and/or a substitution for clinical judgement. Custom and habit often supercede
evidence-based data in impacting a physician's practices ("This is how I was taught to do
it," or "I've always done it this way.") Similar comments were seen in the follow up
survey. Finally, physicians may not perceive the need for the guideline ("I've never had
a problem using Benadryl before.") There was no perceived need or incentive for
change, critical factors in practice alteration. Further research in this area would attempt
to survey more house staff on a broader variety of services, perhaps in a focus group
setting.
Of note, a true decision support system is necessary to fully optimize the use of
electronic reminders. This includes the implementation of an electronic medical record
such that reminders can be patient-specific. As YNHH progresses to using such a
system, the impact of electronic reminders will likely be more pronounced.
8.2 Limitations of the Study
The following factors may have contributed to a reduced ability to assess the
impact of the electronic reminder. As mentioned above, there are alternate sources of
order entry that do not activate the screen. The proportion of residents in the follow-up
survey that had not seen the screen may be ordering blood from an alternate source.
However, unless they were on oncologic rotations, it is more likely that the residents
simply did not order blood as often, rather than having ordered from an alternate
pathway. Another limitation is that the house staffmay have ordered diphenhydramine at
the start of the first unit of transfusion, but not for consecutive episodes. If this factor is
significant, this study underestimates the rate of diphenhydramine use, and yet still shows
a significant reduction after implementation of the electronic reminder.
Another factor contributing to an underestimation of actual diphenhydramine use
is the clinical scenario where the patient is already receiving the medication for other
reasons (e.g., as a sedative/hypnotic, as an antihistamine for non-transfusion related
reasons). When the patient has a standing order, clinicians will not likely enter a pre-
transfusion order, and thus it would not be included in this study. A final contributing
factor is that house staff are often not the ultimate decision makers in the care of the
patient, and ordering diphenhydramine as a pretreatment may not reflect their actual
intentions or awareness, but rather that of the attending physician.
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Finally, the assessment ofmental status change was done in an unblinded fashion.
Though the researcher evaluated each record for documentation of cognitive decline
regardless of treatment status, the lack of formal criteria for this evaluation may have
biased the results in favor of discovering more mental status change in the treated group.
Part IX: Impact on Patient Outcomes
9.1 Diphenhydramine andMental Status Change
The data reflect a significant association between increased diphenhydramine use
and documentation ofmental status change. Data from elsewhere(72, 73) as well as a
study at this particular institution characterizes the relationship between diphenhydramine
use and mental status change. The electronic reminder served to significantly decrease
the use of diphenhydramine and thus likely impacted adverse events associated with the
overuse of the medication. Further research is warranted to assess the economic impact
of this reduction in medication use in terms of probable reduction in antipsychotic use,
psychiatric and neurologic consultations, use of restraints, and length of stay.
This study evaluated documentation of mental status change in all transfusion
episodes regardless of diphenhydramine use. The rate of cognitive decline was
significantly higher than in the control group (39% vs. 18%). Therefore, it is unlikely
that the change in mental status was due to the blood transfusion, but rather to the
administration of diphenhydramine.
9.2 Limitations ofStudy
Confounding factors may have adversely affected the study's ability to assess
patient outcomes. Poor documentation within the medical record may underestimate the
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occurrence of mental status changes. Alternatively, central nervous system (CNS) effects
may have been due to co-morbid conditions, such as baseline dementia, hepatic
encephalopathy, meningitis, and a post-ictal or a post-operative state. Future studies in
this area would assess patient outcomes with formal criteria for drug-induced CNS effects
(e.g., Folstein Mini-Mental Status Exam, Confusion Assessment Method criteria).
Conclusion
The practice ofAmerican medicine continues to adjust to turbulent times. The
changing demographics of this nation, increased cost of health care, prevalence of health
care rationing, and frequency ofmedical errors and adverse events call for a reevaluation
of the delivery of health care in the United States. Inappropriate care results from the
inadequate production, evaluation, dissemination, and use of information. (69) Clinical
guidelines can be helpful in supporting the improved acquisition and use of information.
However, physician decisions, actions, and behavior are often not based on
cost/benefit evaluations, but are guided by habit and custom, by assumptions, beliefs, and
values held by peers, and by prevailing practices and social norms that define appropriate
behavior.(61) Dissemination through guidelines alone is not sufficient, but it remains a
necessary first step. This study sought to evaluate the effectiveness of electronic
dissemination. This mechanism was a simple intervention at the time of decision making
that had a marked effect over time. In this study, electronic dissemination was a
sustainable mechanism that impacted physician practice patterns. This method can be
applied to other measures of quality and performance and contribute to total quality
management within an institution.
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Clinical guidelines and quality improvement seek to improve the system of health
care delivery through continuous assessment and evaluation. Though neither a consensus
panel nor a computer should dominate decisions about the treatment of a patient, as long
as the patient's best interest is kept at the forefront, this shall not come to pass.
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